Enrollment Info Updated on Phase 3 Trial Assessing AeroVanc for MRSA Infection in CF
cystic fibrosis, News
Enrollment for a Phase 3 clinical trial testing AeroVanc in patients with cystic fibrosis with methicillin-resistant Staphylococcus aureus (MRSA) lung infections is expected to be completed in the third quarter of ... Read more